News | April 17, 2007

Siemens' 350th 3T MagnetomTrio MRI Installed

April 18, 2007 - Siemens Medical Solutions recently installed its 350th 3T MAGNETOM Trio magnetic resonance imaging (MRI) scanner at South Jersey Radiology Associates P.A. of Voorhees, NJ.

With this installation, the high-field imaging system is demonstrating that it is not only a research tool, but that it can also make an impact in clinical imaging. Additionally, the scanner is one of more than 175 worldwide 3T systems that use Siemens Medical Solutions proprietary Tim (Total imaging matrix) coil architecture, which eliminates the need for patient repositioning and manual coil changes during scans while significantly enhancing image quality.

“The Trio will allow us to advance to the next level by imaging those regions that are still problematic at 1.5T: small joints such as the wrist, forefoot and fingers,” said William F. Muhr, Jr., MD, a radiologist at South Jersey Radiology Associates P.A. “The 3T field strength moves our neuroimaging to the next level with diffusion tensor imaging and fiber tracking. The magnet will also benefit patients with renal impairments who cannot tolerate as much gadolinium contrast. The increased signal-to-noise ratio at 3T allows us to perform body imaging and MRA at reduced contrast doses. While performing these applications, the MAGNETOM Trio also excels at routine knee, hip, spine and brain imaging, allowing us to run a full patient schedule right out of the gate.”

The MAGNETOM Trio meets a wide range of imaging needs, from routine clinical use, to high-end research, combining the system’s fast gradients with one of the largest field-of-view acquisitions and the highest 3T magnet homogeneity. Siemens’ Tim technology enables the MAGNETOM Trio to address challenges encountered with other 3T systems, without compromising image quality. The high signal-to-noise ratio of the MAGNETOM Trio, in combination with Tim technology, enables reduced scan times, which consequently reduces motion artifacts, improves patient comfort and helps increase patient throughput.

“The success of MAGNETOM Trio can be attributed to its excellent performance in all radiological settings, from neurology and orthopedics to angiography and abdominal imaging,” said Nancy Gillen, vice president, MR division, Siemens Medical Solutions. “The Trio has brought advanced 3T MRI to not only leading academic medical centers but to diagnostic imaging centers and smaller hospitals as well. And our patented Tim technology continues to yield innovations as exemplified by the new generation of Siemens MRI systems.”

Related Content

Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
OptiStar Elite injector
Feature | Contrast Media Injectors | March 07, 2018 | Grand View Research Inc.
The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Guerbet Presents Contrast&Care Injection Management Solution at ECR 2018
News | Contrast Media | February 28, 2018
February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns. Gadolinium deposition in the brain has raised concerns about Gadolinium toxicity.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
ACR Introduces New Contrast Reaction Card
News | Contrast Media | February 07, 2018
The American College of Radiology (ACR) introduced a new contrast reaction card that summarizes important steps to be...
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Approval for Pediatric MRI
News | Contrast Media | January 30, 2018
Bracco Diagnostics Inc. announced the labeling of its contrast agent MultiHance has obtained U.S. Food and Drug...
Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
Overlay Init